M.I. Furman - Concepedia

Author

M.I. Furman

University of Massachusetts Chan Medical School

Also Known As

Lori Krueger, M Furman, M I Furman, M. Furman, M. I. FURMAN, M. I. Furman, M.I. FURMAN, M.I. Furman, MI Furman, Moran Furman

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Massachusetts Chan Medical School University of Michigan Johns Hopkins Medicine Johns Hopkins University

About

M.I. Furman is an author at University of Massachusetts Chan Medical School specializing in medicine, thrombosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.4K
2	Public Health	4	4	636
3	Health Sciences	2	2	187
4	Engineering	1	1	28
5	Natural Sciences	1	1	288

M.I. Furman

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Aging and the complexity of cardiovascular dynamics Daniel T. Kaplan, M.I. Furman, Steven M. Pincus, Biophysical Journal AgingCardiovascular DiseaseCardiovascular DynamicsLongevityMedicine	1991	453
The control of actin nucleotide exchange by thymosin beta 4 and profilin. A potential regulatory mechanism for actin polymerization in cells. Pascal J. Goldschmidt‐Clermont, M.I. Furman, D.H. Wachsstock, Molecular Biology of the Cell Molecular RegulationMolecular BiologyCytoskeletonActin PolymerizationCellular Physiology	1992	288
Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events Keith A.A. Fox, Kim A. Eagle, M.I. Furman, European Heart Journal	2008	119
Indices of platelet activation and the stability of coronary artery disease Matthew D. Linden, M.I. Furman, Andrew L. Frelinger, Journal of Thrombosis and Haemostasis ThrombopoiesisThrombosisCardiovascular DiseaseBlood PlateletAtherosclerosis	2007	117
Evidence that pre‐existent variability in platelet response to ADP accounts for ‘clopidogrel resistance’ Alan D. Michelson, Matthew D. Linden, M.I. Furman, Journal of Thrombosis and Haemostasis ThrombosisCardiovascular DiseasePlatelet ResponseMedicineBlood Platelet	2006	106
Effects of nitric oxide/EDRF on platelet surface glycoproteins Alan D. Michelson, Stephen Benoit, M.I. Furman, American Journal of Physiology-Heart and Circulatory Physiology Nitric OxideGlycobiologyImmunologyWhole BloodPharmacotherapy	1996	102
’Postconditioning’ the human heart: Multiple balloon inflations during primary angioplasty may confer cardioprotection Chad E. Darling, Paolo Solari, Craig S. Smith, Basic Research in Cardiology Multiple Balloon InflationsPercutaneous Coronary InterventionHeart FailureCardiogenic ShockPrimary Angioplasty	2007	91
Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity M.R. BARNARD, Matthew D. Linden, Andrew L. Frelinger, Journal of Thrombosis and Haemostasis InflammationThrombosisThrombopoiesisHealth SciencesBlood Platelet	2005	81
GPIIb–IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention M.I. Furman, Lori A. Krueger, Matthew D. Linden, Journal of Thrombosis and Haemostasis ThrombosisPercutaneous Coronary InterventionCardiovascular DiseaseMedicinePharmacotherapy	2005	54
The platelet surface expression of glycoprotein V is regulated by two independent mechanisms: proteolysis and a reversible cytoskeletal- mediated redistribution to the surface-connected canalicular system AD Michelson, SE Benoit, M.I. Furman, Blood	1996	45

Page 1